Product Information

DIAZEPAM 10 MG RECTAL GEL SYRG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $212.5094 per EA under NDC 43386028002. Its NADAC has been published 144 times since Feb 14, 2024.

FDA first approved this application on May 30, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIAZEPAM 10 MG RECTAL GEL SYRG

Diazepam
$212.5094per EA
DEA Schedule CIV

Strength

10 mg/2g

NDC

43386028002

Classification

Generic

Dosage Form

GEL

Route

RECTAL

Effective Date

10/21/2026

Active Ingredients

DIAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA091076

FDA Approved

5/30/2023

TE Code

AB

On Market Since

10/30/2023

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for DIAZEPAM 10 MG RECTAL GEL SYRG has been published 144 times since Feb 14, 2024, and over the history we have for it it has declined 16.2%. The table below summarizes its recorded NADAC range and movement.

Current price$212.5094 per EA
All-time high$277.6770 (Oct 16, 2024)
All-time low$187.4787 (Apr 22, 2026)
52-week high$241.2186
52-week low$187.4787
Median price$249.6760
Average price$235.2942
Largest weekly change+30.3% (Aug 21, 2024)
Weeks tracked144
Tracking sinceFeb 14, 2024

Price History

1W

0.0%

1M

+1.8%

3M

+4.3%

6M

+13.4%

1Y

-18.6%

3Y

N/A

5Y

N/A

All

-16.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diazepam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIAZEPAM 10 MG RECTAL GEL SYRG?

The current National Average Drug Acquisition Cost (NADAC) for DIAZEPAM 10 MG RECTAL GEL SYRG, manufactured by Lupin Pharmaceuticals Inc., is $212.5094 per EA (NDC 43386028002), effective Nov 11, 2026.

How has the price of DIAZEPAM 10 MG RECTAL GEL SYRG changed over time?

Over the history we have for it, the NADAC for DIAZEPAM 10 MG RECTAL GEL SYRG has declined 16.2%. It has been tracked across 144 weekly CMS publications since Feb 14, 2024.

What are the highest and lowest recorded NADAC prices for DIAZEPAM 10 MG RECTAL GEL SYRG?

Since Feb 14, 2024, the NADAC for DIAZEPAM 10 MG RECTAL GEL SYRG has ranged from a low of $187.4787 (Apr 22, 2026) to a high of $277.6770 (Oct 16, 2024), with a median of $249.6760 per EA.

Are there cheaper alternatives to DIAZEPAM 10 MG RECTAL GEL SYRG?

No other NADAC-published product currently shares the active ingredient and strength of DIAZEPAM 10 MG RECTAL GEL SYRG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DIAZEPAM 10 MG RECTAL GEL SYRG?

DIAZEPAM 10 MG RECTAL GEL SYRG (NDC 43386028002) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.